Azithromycin Tablet, Film Coated
FDA Label NDC 50111-787

46 label sections · Submitted to the FDA by Teva Pharmaceuticals Usa, Inc. · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Teva Pharmaceuticals Usa, Inc. for the product Azithromycin (NDC 50111-787). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding 1.1 indications in adult patients, 1.2 indications in pediatric patients, 1.3 limitations of use, 1.4 usage, 2.1 recommended dosage for adult patients, 2.2 recommended dosage for pediatric patients, 2.3 pediatric dosage guidelines for pharyngitis/tonsillitis, 3 dosage forms and strengths, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

* Please review the disclaimer below.